Publication:
Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Simple item page
dc.contributor.authorsEsin, E.; Oksuzoglu, O. B. Cakmak; Bilici, A.; Cicin, I.; Aksoy, S.; Alacacioglu, A.; Kaplan, M. A.; Cabuk, D.; Sumbul, A. T.; Paydas, S.; Sakin, A.; Er, O.; Korkmaz, T.; Yildirim, N.; Artac, M.; Harputluoglu, H.; Yumuk, P. F.; Basaran, G.; Uluc, B. Oyan; Demirci, U.
dc.date.accessioned2022-03-12T16:24:02Z
dc.date.accessioned2026-01-11T19:19:56Z
dc.date.available2022-03-12T16:24:02Z
dc.date.issued2018
dc.identifier.doidoiWOS:000459277300323
dc.identifier.eissn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11424/226183
dc.identifier.wosWOS:000459277300323
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofANNALS OF ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage105
oaire.citation.startPage104
oaire.citation.titleANNALS OF ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları